EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr | ₹309 Cr |
What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,888 Cr |
| Mar2024 | ₹1,044 Cr |
| Mar2023 | ₹817 Cr |
| Mar2022 | ₹459 Cr |
| Mar2021 | ₹309 Cr |
How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,888 Cr | 80.80 | |
| Mar2024 | ₹1,044 Cr | 27.83 | |
| Mar2023 | ₹817 Cr | 77.83 | |
| Mar2022 | ₹459 Cr | 48.50 | |
| Mar2021 | ₹309 Cr | - | |
Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,884.6 Cr | 0% | 2.4% | 41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 0% |
2.4% |
41.7% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses